Literature DB >> 21410796

Comparison of the Cytobrush®, dermatological curette and oral CDx® brush test as methods for obtaining samples of RNA for molecular analysis of oral cytology.

M D Reboiras-López1, M Pérez-Sayáns, J M Somoza-Martín, P Gayoso-Diz, F Barros-Angueira, J M Gándara-Rey, A García-García.   

Abstract

OBJECTIVE: Interest in oral exfoliative cytology has increased with the availability of molecular markers that may lead to the earlier diagnosis of oral squamous cell carcinoma. This research aims to compare the efficacy of three different instruments (Cytobrush, curette and Oral CDx brush) in providing adequate material for molecular analysis.
METHODS: One hundred and four cytological samples obtained from volunteer healthy subjects were analysed using all three instruments. The clinical and demographical variables under study were age, sex and smoking habits. The three instruments were compared for their ability to obtain adequate samples and for the amount of RNA obtained using quantitative real-time polymerase chain reaction (PCR-qRT) analysis of the Abelson (ABL) housekeeping gene.
RESULTS: RNA of the ABL gene has been quantified by number of copies. Adequate samples were more likely to be obtained with a curette (90.6%) or Oral CDx (80.0%) than a Cytobrush (48.6%); P < 0.001. Similarly, the RNA quantification was 17.64 ± 21.10 with a curette, 16.04 ± 15.81 with Oral CDx and 6.82 ± 6.71 with a Cytobrush. There were statistically significant differences between the Cytobrush and curette (P = 0.008) and between the Cytobrush and OralCDx (P = 0.034). There was no difference according to the demographical variables.
CONCLUSIONS: Oral exfoliative cytology is a simple, non-invasive technique that provides sufficient RNA to perform studies on gene expression. Although material was obtained with all three instruments, adequate samples were more likely to be obtained with the curette or Oral CDx than with a Cytobrush. The Oral CDx is a less aggressive instrument than the curette, so could be a useful tool in a clinical setting.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21410796     DOI: 10.1111/j.1365-2303.2011.00860.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  5 in total

1.  Comparison of RNA Extraction Methods for Molecular Analysis of Oral Cytology.

Authors:  Mônica Ghislaine Oliveira Alves; Mario Pérez-Sayáns; Maria-Elena Padín-Iruegas; Maria Dolores Reboiras-López; José Manuel Suarez-Peńaranda; Rafael López-López; Celina Faig Lima Carta; Jaqueline Scholz Issa; Abel García-García; Janete Dias Almeida
Journal:  Acta Stomatol Croat       Date:  2016-06

Review 2.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Richard Macey; Tanya Walsh; Paul Brocklehurst; Alexander R Kerr; Joseph L Y Liu; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

3.  An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas.

Authors:  Nadja Kokalj Vokač; Bogdan Cizmarević; Andreja Zagorac; Boris Zagradišnik; Boštjan Lanišnik
Journal:  Mol Cytogenet       Date:  2014-01-10       Impact factor: 2.009

4.  Clinicopathologic factors influencing the screening accuracy of oral cytology: A retrospective cohort study.

Authors:  Masami Kawaharada; Satoshi Maruyama; Manabu Yamazaki; Tatsuya Abé; Nyein Nyein Chan; Akinori Funayama; Atsushi Uenoyama; Toshiyuki Akimori; Kei Tomihara; Jun-Ichi Tanuma
Journal:  Oncol Lett       Date:  2022-09-15       Impact factor: 3.111

5.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Tanya Walsh; Richard Macey; Alexander R Kerr; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.